A comparative trial of BCG vaccine intradermal doses of 0.05mg and 0.025mg in newborns and infants aged 1-90 days
- Author:
Ling Hong Nguyen
- Publication Type:Journal Article
- Keywords:
vaccine
- MeSH:
BCG Vaccine;
Pharmaceutical Preparations;
child;
Infant, Newborn
- From:Journal of Preventive Medicine
1998;8(3):5-10
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
The study was conducted in 796 newborns and infants aged 1-90 days. The newborns were randomly divided into three groups receiving different doses (0.05mg and 0.025mg) of Nha Trang BCG vaccine and 0.05mg of Pasteur BCG vaccine, intradermally. The results showed that the tuberculin conversion was satisfactory in both groups (receiving 0.05mg and 0.025mg dose of Nha Trang BCG vaccine), while the percentage of suppurative adenitis was found significantly higher in the group receiving 0.05mg BCG vaccine
